The literature in respect to these variants in BCL2, CASP3, CASP9, and TP53 genes is scarce, especially regarding BC; one study from our research group sought to associate these variants with gastric cancer in the Brazilian population, with no statistical significance [13]. The gene discussed is BCL2; the disease is gastric cancer.